About Childhood AML
- AML is most common in infants.
- After five years, nearly half of all children treated for AML haven't experienced a return of the disease (remission).
- Children under age 2 have a lower chance of remission and cure than do older children.
Because of new and better therapies, cancer survival rates for children have improved dramatically during the last several decades. Scientists continue to search for the causes of childhood leukemia so they can develop better treatments with less toxic side effects.